Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004369806 | SCV004856455 | uncertain significance | not specified | 2024-08-01 | criteria provided, single submitter | clinical testing | The c.998C>T (p.P333L) alteration is located in exon 8 (coding exon 8) of the DIP2A gene. This alteration results from a C to T substitution at nucleotide position 998, causing the proline (P) at amino acid position 333 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003936913 | SCV004756581 | likely benign | DIP2A-related disorder | 2022-08-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |